More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents
Condition(s):HIV InfectionsLast Updated:August 3, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):HIV InfectionsLast Updated:August 3, 2023Recruiting
Condition(s):HIV InfectionsLast Updated:April 14, 2023Completed
Condition(s):HIV-1-infectionLast Updated:March 15, 2024Recruiting
Condition(s):HIV InfectionsLast Updated:July 20, 2023Recruiting
Condition(s):HIV-1-infection; Pregnancy; PostpartumLast Updated:March 28, 2024Not yet recruiting
Condition(s):HIV-1-infectionLast Updated:October 23, 2023Recruiting
Condition(s):HIV InfectionsLast Updated:February 15, 2024Active, not recruiting
Condition(s):HIV InfectionsLast Updated:October 24, 2023Completed
Condition(s):Hiv; HIV Infections; HIV-1-infection; Paediatric Human Immunodeficiency Virus InfectionLast Updated:February 9, 2024Recruiting
Condition(s):HIVLast Updated:April 5, 2021Approved for marketing
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.